These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1128161)

  • 1. Oligopeptide control of step-down avoidance.
    Guttman HN; Cooper RS
    Life Sci; 1975 Mar; 16(6):915-23. PubMed ID: 1128161
    [No Abstract]   [Full Text] [Related]  

  • 2. [Conditioned reaction of active avoidance in rats administered the delta-sleep peptide].
    Murashov AK
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1986; 36(1):121-3. PubMed ID: 3754675
    [No Abstract]   [Full Text] [Related]  

  • 3. Attenuation of memory with Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog with high affinity for mu-opioid receptors.
    Ukai M; Kobayashi T; Mori K; Shinkai N; Sasaki Y; Kameyama T
    Eur J Pharmacol; 1995 Dec; 287(3):245-9. PubMed ID: 8991797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endomorphins 1 and 2, endogenous mu-opioid receptor agonists, impair passive avoidance learning in mice.
    Ukai M; Watanabe Y; Kameyama T
    Eur J Pharmacol; 2001 Jun; 421(2):115-9. PubMed ID: 11399267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reputed rat scotophobin prepared by a solid-phase procedure shown invalid by comparison with a product derived from a classical synthesis on the basis of physical and biological properties.
    Guttman HN; Weinstein B; Bartschot RM; Tam PS
    Experientia; 1975 Mar; 31(3):285-8. PubMed ID: 1167829
    [No Abstract]   [Full Text] [Related]  

  • 6. Action of substance P and an SP-hexapeptide analogue on avoidance learning in rats.
    Hecht K; Oehme P; Poppei M
    Pharmazie; 1982 Nov; 37(11):791-2. PubMed ID: 6187027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Avoidance conditioned-reflex behavior in rats chronically administered leucine enkephalin and its synthetic tetrapeptide analog into the neostriatum].
    Suvorov NF; Iakimovskiĭ AF; Eremeev AV; Bobrova IV
    Fiziol Zh SSSR Im I M Sechenova; 1989 Jun; 75(6):745-51. PubMed ID: 2806641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain acetylcholine and excitation in avoidance behavior.
    Aprison MH; Hingtgen JN
    Biol Psychiatry; 1969 Jan; 1(1):87-9. PubMed ID: 5367324
    [No Abstract]   [Full Text] [Related]  

  • 9. Alpha-amanitin inhibition of mouse brain form II ribonucleic acid polymerase and passive avoidance retention.
    Thut PD; Lindell TJ
    Mol Pharmacol; 1974 Jan; 10(1):146-54. PubMed ID: 4858681
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulation of delta1- and delta2-opioid receptors produces amnesia in mice.
    Ukai M; Takada A; Sasaki Y; Kameyama T
    Eur J Pharmacol; 1997 Oct; 338(1):1-6. PubMed ID: 9407996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of the oligopeptide sleep neuromodulator in rats, rabbits and dogs].
    Medvedev VI; Bakharev VD
    Zh Evol Biokhim Fiziol; 1979; 15(4):379-84. PubMed ID: 473994
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological effects of N-butyl-scopolamine in comparison with scopolamine].
    Xiao HL; Qu ZW; Zhang JT
    Yao Xue Xue Bao; 1987 Jul; 22(7):481-5. PubMed ID: 2835883
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulatory and inhibitory analogs of luteinizing hormone releasing hormone.
    Coy DH; Coy EJ; Schally AV; Vilchez-Martinez JA; Debeljuk L; Carter WH; Arimura A
    Biochemistry; 1974 Jan; 13(2):323-6. PubMed ID: 4589308
    [No Abstract]   [Full Text] [Related]  

  • 14. Blocking the ghrelin receptor type 1a in the rat brain impairs memory encoding.
    Beheshti S; Shahrokhi S
    Neuropeptides; 2015 Aug; 52():97-102. PubMed ID: 26072187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-way (shuttle-box) avoidance in rats after paraoxon treatment.
    Rosić N; Milosević M
    Act Nerv Super (Praha); 1971 Nov; 13(4):241-5. PubMed ID: 5142714
    [No Abstract]   [Full Text] [Related]  

  • 16. The head activator: discovery, characterisation, immunoassays and biological properties in mammals.
    Bodenmüller H; Roberge M
    Biochim Biophys Acta; 1985 Jul; 825(3):261-7. PubMed ID: 2410027
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperalgesia, low-anxiety, and impairment of avoidance learning in neonatal caffeine-treated rats.
    Pan HZ; Chen HH
    Psychopharmacology (Berl); 2007 Mar; 191(1):119-25. PubMed ID: 17096081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tripeptide protease inhibitor attenuates conditioned avoidance behavior.
    Davis JL; Pico RM
    Brain Res; 1987 Mar; 406(1-2):10-6. PubMed ID: 3567620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cortexin and cortagen as correcting agents in functional and metabolic disorders in the brain in chronic ischemia].
    Zarubina IV; Shabanov PD
    Eksp Klin Farmakol; 2011; 74(2):8-15. PubMed ID: 21476278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of substance P and fragments on passive avoidance behavior.
    Gaffori O; Stewart JM; de Wied D
    Experientia; 1984 Jan; 40(1):89-91. PubMed ID: 6198204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.